Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avicanna Inc (OP: AVCNF )

0.1898 -0.0031 (-1.61%)
Streaming Delayed Price Updated: 9:42 AM EDT, May 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 17,500
Open 0.1898
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1929
Today's Range 0.1898 - 0.1898
52wk Range 0.1862 - 0.5320
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CBD-Focused Avicanna Reports First-Ever Adjusted EBITDA Positive Quarter, 451% YoY Spike In Q1 Record Revenue
Cannabis-focused biopharmaceutical company Avicanna Inc. announced on Tuesday financial results for the first quarter of fiscal 2024.CEO Aras Azadian called it its "best quarter." In addition to being... 
Via Benzinga
CBD Helps With This Rare Blistering Skin Disorder, New Study From Avicanna Shows Promising Results In Epidermolysis Bullosa Treatment
There is no cure for a rare blistering skin disorder called Epidermolysis Bullosa (EB). But, treatments to help alleviate and control the symptoms do exist. The growing body of research suggests... 
Via Benzinga
Topics Cannabis
Exposures Cannabis

Performance

YTD
-23.31%
-23.31%
1 Month
-32.36%
-32.36%
3 Month
-42.66%
-42.66%
6 Month
-28.59%
-28.59%
1 Year
-31.53%
-31.53%

More News

Read More
Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY
Via Benzinga
Topics Cannabis
Exposures Cannabis
This Company Is Bringing Medical Marijuana Telehealth To Over Half The U.S.
Via Benzinga
Topics Cannabis
Exposures Cannabis
Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global
Via Benzinga
Topics Cannabis
Exposures Cannabis
CBD-Focused Avicanna Taps Into European Market Via Exclusive Pharma Supply Deal
Via Benzinga
CBD-Focused Avicanna Announces Funding Boost For Research And Development
Via Benzinga
Avicanna Inc.: Medical Marijuana Sales Reach Record 713% YoY Growth In Q3, Introduces New Platform
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From August 25, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For August 23, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Canadian Cannabis Producer Reports Revenue Spike And Improved Margins In Q2, But What About Net Loss?
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers
Via Benzinga
Cannabis Stock Gainers And Losers From August 16, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
This Cannabis Company Just Launched Medical Marijuana Care Platform And Finalized Important Acquisition
Via Benzinga
Cannabis Stock Movers For August 10, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Avicanna Reveals The Initial Network Of Brands On Its Cannabis Care Platform
Via Benzinga
Cannabis Stock Gainers And Losers From July 25, 2023
Via Benzinga
Marijuana Stock Movers For August 8, 2023
Via Benzinga
European Cannabis Q2 2023 Quarterly Update
Via Talk Markets
Avicanna's SMGH Exports Aureus Branded CBD And CBG Into Paraguay
Via Benzinga
Cannabis Stock Gainers And Losers From August 4, 2023
Via Benzinga
Two Pot Companies Continue To Focus On Cannabinoid-Based Self-Emulsifying Drug Delivery Systems
Via Benzinga
Avicanna Sponsors New Medical Cannabis Education And Training Campaign In Canada
Via Benzinga
Marijuana Stock Movers For July 31, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.